AJP - Endocrinology and Metabolism, Vol 272, Issue 4 E607-E615, Copyright © 1997 by American Physiological Society

ARTICLES

Insulin receptor mRNA splicing and altered metabolic control in aged and mildly insulin-deficient rats

M. M. Wiersma, D. Auboeuf, I. M. Nieuwenhuizen-Bakker, J. K. Radder, J. P. Riou and H. Vidal
Department of Endocrinology and Metabolic Diseases, University Hospital Leiden, The Netherlands.

Using reverse transcription-competitive polymerase chain reaction, we measured the abundance of the mRNAs encoding the two spliced isoforms of insulin receptor in aged and mildly insulin-deficient rats. Twelve-month-old rats were characterized by peripheral insulin resistance and decreased glucose tolerance. Mild insulin deficiency, obtained by neonatal streptozotocin treatment, was associated with glucose intolerance due to reduced glucose-stimulated insulin response. Both models were associated with a decrease in the relative abundance of the mRNA with exon 11 in liver, heart, adipose tissue, and tibialis muscle, whereas a slight increase was seen in the extensor digitorum longus and no change in the soleus muscle. In the three muscles, the expression of the form without exon 11 largely predominated (>90%). In heart and adipose tissue, the two isoforms were expressed at a similar level in control rats. In both tissues, the form without exon 11 increased in streptozotocin-treated rats, whereas the absolute level of the form with exon 11 decreased in old rats. Although a decreased level of the variant with exon 11 correlated with insulin resistance of whole body glucose uptake, our results indicated that changes in the expression of the insulin receptor variants were secondary events and thus not the cause of the insulin resistance in old and mildly insulin-deficient rats.

This article has been cited by other articles:

				R Serrano, M Villar, C Martinez, J M Carrascosa, N Gallardo, and A Andres Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat adipose tissue J. Mol. Endocrinol., February 1, 2005; 34(1): 153 - 161. [Abstract] [Full Text] [PDF]

				M. D. McArthur, D. You, K. Klapstein, and D. T. Finegood Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E739 - E746. [Abstract] [Full Text] [PDF]